RESTON, Va., June 28, 2011 /PRNewswire/ — The Mirixa
Corporation and the Canadian Association of Chain Drug Stores
(CACDS) are pleased to announce that MirixaPro(SM), a Web-based
clinical platform that supports and documents standardized,
pharmacy-based patient care service delivery, will be deployed in
Canada. The two organizations signed a 10-year licensing agreement
enabling CACDS to use a scalable, localized version of the
MirixaPro platform.
(Logo: http://photos.prnewswire.com/prnh/20100818/SF51721LOGO)
CACDS members represent more than 6,200 pharmacies and dispense
70% of Canada’s prescriptions each year. The deployment of
MirixaPro will enable Canada’s most active pharmacies to more
efficiently augment their dispensing services with enhanced
pharmacy services including comprehensive medication management.
MirixaPro will enable pharmacists to document patient progress,
identify compliance issues, and supply educational materials. This
information can then be shared with patients’ other care providers,
fostering greater care and inter-professional collaboration and
ultimately optimizing health outcomes.
Nadine Saby, President and CEO of CACDS comments, “Community
pharmacy in Canada is in the early stages of significant
professional practice evolution and payers are moving to establish
reimbursement for these new pharmacy services, recognizing the
value in improved patient health and well-being and cost
effectiveness to the health care system. To better enable the
delivery of these services, CACDS looked for a tool that would help
standardize the deployment of clinical pharmacy services across the
country through the use of a common technology platform. We
evaluated a number of solutions and were impressed with the
strength of the MirixaPro platform and the robustness of its
capabilities.”
“Worldwide, patient engagement is considered a necessary
componen
‘/>”/>
SOURCE